{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Zhejiang Wolwo Bio-Pharmaceutical Hits Day Low Amid Price Pressure at CNY 23.28
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. saw a significant stock decline on March 23, 2026, reaching an intraday low. Over the past month, the stock has dropped notably, while the company maintains a strong market position in the pharmaceuticals sector, with a market capitalization of CNY 12,510 million.
Zhejiang Wolwo Stock Hits Day High with Strong 4.39% Intraday Surge
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. has experienced notable stock activity, outperforming the Shanghai Composite over the past week. Despite recent challenges, the company has shown resilience with a strong annual performance. Financially, it maintains a solid market capitalization and favorable metrics, positioning it well in the pharmaceuticals sector.
Zhejiang Wolwo Bio-Pharmaceutical Hits Day Low Amid Price Pressure at CNY 24.51
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. faced a significant stock decline today, contrasting with the broader market's performance. Despite recent challenges, the company has generated a positive return over the past year. It maintains a strong cash position and a notable return on equity, reflecting its resilience in the pharmaceuticals sector.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Mixed Financial Results Amid Market Challenges
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported challenging financial results for the quarter ending March 2025. Despite this, the company saw a decrease in raw material costs and achieved its highest cash position, indicating strong liquidity. Additionally, an improved debtors turnover ratio reflects effective receivables management.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
